Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer

Assessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administra...

Full description

Saved in:
Bibliographic Details
Main Authors: T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/35
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849403738266009600
author T. Yu. Semiglazova
V. V. Semiglazov
L. V. Filatova
P. V. Krivorotko
V. V. Kolarkova
V. F. Semiglazov
author_facet T. Yu. Semiglazova
V. V. Semiglazov
L. V. Filatova
P. V. Krivorotko
V. V. Kolarkova
V. F. Semiglazov
author_sort T. Yu. Semiglazova
collection DOAJ
description Assessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administration of denosumab significantly improves quality of life in patients with breast cancer metastasizing to the bone, by maintaining their general status, reducing the intensity of pain syndrome, and prevents osseous complications: pathological fractures, spinal cord compression, hypercalcemia, as well as the need for radiotherapy or surgery for bone metastases.
format Article
id doaj-art-3fa905d680954db9ac8cc5c6424d7883
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-3fa905d680954db9ac8cc5c6424d78832025-08-20T03:37:11ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-07-0101-2172210.17650/1994-4098-2013-0-1-2-17-2250Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancerT. Yu. Semiglazova0V. V. Semiglazov1L. V. Filatova2P. V. Krivorotko3V. V. Kolarkova4V. F. Semiglazov5N.N. Petrov Oncology Research Institute, Ministry of Health of Russia, Saint PetersburgAcad. I.P. Pavlov Saint Petersburg State Medical University, Ministry of Health of RussiaN.N. Petrov Oncology Research Institute, Ministry of Health of Russia, Saint PetersburgN.N. Petrov Oncology Research Institute, Ministry of Health of Russia, Saint PetersburgN.N. Petrov Oncology Research Institute, Ministry of Health of Russia, Saint PetersburgN.N. Petrov Oncology Research Institute, Ministry of Health of Russia, Saint PetersburgAssessment of quality of life is an important, valid, informative, and cost-effective procedure for evaluating the efficiency of treatment in patients with breast cancer metastasizing to the bone, receiving therapy with bone-modifying agents, including targeted therapy with denosumab. The administration of denosumab significantly improves quality of life in patients with breast cancer metastasizing to the bone, by maintaining their general status, reducing the intensity of pain syndrome, and prevents osseous complications: pathological fractures, spinal cord compression, hypercalcemia, as well as the need for radiotherapy or surgery for bone metastases.https://ojrs.abvpress.ru/ojrs/article/view/35quality of lifebreast cancerbone metastasesskeletal-related eventsdenosumabzoledronic acid
spellingShingle T. Yu. Semiglazova
V. V. Semiglazov
L. V. Filatova
P. V. Krivorotko
V. V. Kolarkova
V. F. Semiglazov
Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
Опухоли женской репродуктивной системы
quality of life
breast cancer
bone metastases
skeletal-related events
denosumab
zoledronic acid
title Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
title_full Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
title_fullStr Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
title_full_unstemmed Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
title_short Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
title_sort quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
topic quality of life
breast cancer
bone metastases
skeletal-related events
denosumab
zoledronic acid
url https://ojrs.abvpress.ru/ojrs/article/view/35
work_keys_str_mv AT tyusemiglazova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer
AT vvsemiglazov qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer
AT lvfilatova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer
AT pvkrivorotko qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer
AT vvkolarkova qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer
AT vfsemiglazov qualityoflifeisanimportantcriterionfortheefficiencyoftargetedtherapyformetastaticskeletalinvolvementinbreastcancer